Here's Why UiPath (PATH) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PATH's Agentic AI Solutions Could Accelerate Enterprise Adoption
UiPath's push into agentic AI solutions targets a key enterprise gap, aiming to turn pilots into scalable deployments that could drive long-term growth.
UiPath Stock Slides 39% in Six Months: a Buying Opportunity or a Hold?
PATH's 39% slide resets expectations, but steady growth, rising margins and strong cash position keep the stock in hold territory amid demand uncertainty.
UiPath (PATH) Trades 25% Below Analyst Targets After 36% Year-to-Date Slide
UiPath (NYSE:PATH) currently trades at $10.39, while the average analyst price target sits at $13.80, implying upside of roughly 33% from current levels.
Why Is UiPath (PATH) Down 12.6% Since Last Earnings Report?
UiPath (PATH) reported earnings 30 days ago. What's next for the stock?
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath, Inc. (PATH) Discusses Product Strategy, Roadmap, and Agentic Business Orchestration Capabilities Transcript
UiPath, Inc. (PATH) Discusses Product Strategy, Roadmap, and Agentic Business Orchestration Capabilities Transcript
Options Traders Can't Get Enough of UiPath Stock
Shares of UiPath Inc (NYSE:PATH) are down 0.5% to trade at $11.19 at last glance, extending their multi-month pullback from its early December 52-week high.
UiPath: My Buy Zone Has Materialized - Agentic Automation Beneficiary
PATH has proven their AI beneficiary status, with the new workflows from the broader Agentic AI boom triggering the higher adoption of their unified agentic automation platform. The same has been observed in the accelerating per-seat monetization compared to a year ago, with the recent SaaSpocalypse selloff mostly sentiment driven instead of fundamentals. PATH now trades at a discounted EV/Sales of 2.37x, while reporting an excellent FY2026 Rule of 36% outperformance (revenue growth/FCF margin).
Sitting On $1.69B In Cash: Why UiPath Is Too Cheap To Ignore
UiPath trades at a compelling valuation, with net cash comprising ~30% of market cap and robust GAAP profitability. PATH delivered 11% YoY ARR growth to $1.853B, exceeding guidance, and raised its long-term non-GAAP operating margin target to 30%. Despite AI disruption fears, PATH's 97% gross retention rate and critical workflow integration underscore business stickiness and resilience.
UiPath: Buying Agentic AI At A 40% Discount
Despite PATH's 30% year-to-date decline, the stock remains attractive as the correction was primarily driven by broader market conditions. Currently, PATH shares trade at a significant 40% discount to peers based on EV/Sales and EV/EBITDA multiples. The transition to agent-based AI is already underway, contributing $200 million in sales growth from new products.
UiPath: With Meaningful ARR Growth, This Company Has True AI Tailwinds
UiPath remains fundamentally strong despite a ~30% YTD share price decline and broader SaaS sector pessimism. PATH continues to deliver double-digit revenue growth, expanding ARR, and robust net revenue retention, signaling resilience against AI disruption fears. The market undervalues PATH, pricing it as a disruption candidate, while its proven automation platform and industry recognition reinforce its competitive moat.
